caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1134228679

Betty CervenakM.D.

PRACTICEPALISADE EYE ASSOCIATES,P.C.See all providers at this practice →
OphthalmologyJersey City, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
182
Unique beneficiaries
—
Total services
193
Distinct HCPCS
5
Medicare payment
$14K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 531 Ophthalmology providers in NJ — bottom quintile (cohort median 2,470).
REFERRAL NETWORK

Where Betty Cervenak's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 7 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2434
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
HUDSON HOSPITAL OPCO LLC2328
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2029
Quest Diagnostics Incorporated
Clinical Laboratory · Clifton, NJ
1625
JERSEY CITY MEDICAL CENTER1522
ACCURATE DIAGNOSTICS LABS, INC.1421
Anthony Panariello
Ophthalmology · Jersey City, NJ
1432
NPI 14179050191441
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
311
Beneficiaries
—
Total drug cost
$231K
Distinct drugs
7
Brand share
62.7%
Top prescribed drugs
Lifitegrast78 claims
Cyclosporine74 claims
Latanoprost54 claims
Cyclosporine32 claims
Tobramycin/Dexamethasone22 claims
QUALITY · MIPS · 2024
Final MIPS score
90.9
Quality
96.3
Cost
73.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.67%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$66
Payment records
4
By payment type
Food and Beverage$66